Research and Education

Papers in Refereed Journals

1.    Georgiades MJ, Wilson D, Garcia M, Boland-Freitas R, Morales-Briceño H, Mahant N, Fung VSC, Martin A. Not So Smooth Sailing: FIG4-Related Disease Is a Differential Diagnosis of Rapid Onset Dystonia-Parkinsonism. Mov Disord Clin Pract. 2025 Mar 21. Online ahead of print. PMID:40118803

2.    Rudaks LI, Stevanovski I, Yeow D, Reis ALM, Chintalaphani SR, Cheong PL, Gamaarachchi H, Worgan L, Ahmad K, Hayes M, Hannaford A, Kim S, Fung VSC, Halmagyi GM, Martin A, Manser D, Tchan M, Ng K, Kennerson ML, Deveson IW, Kumar KR. Targeted Long-Read Sequencing as a Single Assay Improves the Diagnosis of Spastic-Ataxia Disorders. Ann Clin Transl Neurol. 2025 Feb 25. Online ahead of print. PMID:40007153

3.    Waller SE, Stockwell JB, Fung VSC, Anstey KJ, Colebatch JG, Markoulli M, Krishnan AV. Topical review: Ocular surface abnormalities in neurodegenerative disorders. Optom Vis Sci. 2025 Jan 9. Online ahead of print. PMID: 39792646

4.    Trewin BP, Dale RC, Qiu J, Chu M, Jeyakumar N, Dela Cruz F, Andersen J, Siriratnam P, Ma KKM, Hardy TA, van der Walt A, Lechner-Scott J, Butzkueven H, Broadley SA, Barnett MH, Reddel SW, Brilot F, Kalincik T, Ramanathan S; Australasian MOGAD Study Group. Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse. J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1054-1063. PMID: 38744459

5.    Nagaratnam SA, Harinesan N, Silsby M, Fung VSC. Unilateral Upper-Limb Tremor Due to C6 Radiculopathy and Demyelinating Neuropathy. Mov Disord Clin Pract. 2024 Oct;11(10):1287-1290. PMID: 39212305

6.    Reynolds M, Tan I, Nguyen K, Merheb V, Lee FXZ, Trewin BP, Lerch M, Shah S, Wolfe N, Buzzard K, Lechner-Scott J, Fabis-Pedrini M, Fok A, John N, Kneebone C, Yiannikas C, Brown DA, Kermode AG, Reddel S, Dale RC, Brilot F, Ramanathan S; Australasian MOGAD Study Group. The clinical relevance of MOG antibody testing in cerebrospinal fluid. Ann Clin Transl Neurol. 2024 Sep;11(9):2514-2519. PMID: 39073255

7.    Fellner A, Wali GM, Mahant N, Grosz BR, Ellis M, Narayanan RK, Ng K, Davis RL, Tchan MC, Kotschet K, Yeow D, Rudaks LI, Siow SF, Wali G, Yiannikas C, Hobbs M, Copty J, Geaghan M, Darveniza P, Liang C, Williams LJ, Chang FCF, Morales-Briceño H, Tisch S, Hayes M, Whyte S, Kummerfeld S, Kennerson ML, Cowley MJ, Fung VSC, Sue CM, Kumar KR. Genome sequencing reanalysis increases the diagnostic yield in dystonia. Parkinsonism Relat Disord. 2024 Jul;124:107010. PMID: 38772265

8.    Silsby M, Yiannikas C, Fois AF, Kennerson ML, Kiernan MC, Fung VSC, Vucic S. Upper and lower limb tremor in Charcot-Marie-Tooth neuropathy type 1A and the implications for standing balance. J Neurol. 2024 Apr;271(4):1776-1786. PMID: 38051345

9.    Fung VSC, Aldred J, Arroyo MP, Bergquist F, Boon AJW, Bouchard M, Bray S, Dhanani S, Facheris MF, Fisseha N, Freire-Alvarez E, Hauser RA, Jeong A, Jia J, Kukreja P, Soileau MJ, Spiegel AM, Talapala S, Tarakad A, Urrea-Mendoza E, Zamudio J, Pahwa R. Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance. Clin Park Relat Disord. 2024 Feb 10;10:100239. PMID: 38419617

10.  Silsby M, Yiannikas C, Fois AF, Kiernan MC, Fung VSC, Vucic S. Upper and lower limb tremor in inflammatory neuropathies. Clin Neurophysiol. 2024 Feb;158:69-78. PMID:38194761  

11.  Beylergil SB, Mukunda KN, Elkasaby M, Perlmutter JS, Factor S, Bäumer T, Feurestein J, Shelton E, Bellows S, Jankovic J, Mahajan A, Wamer-Rosen T, Reich SG, Shukla AW, Malaty I, Espay A, Duque K, LeDoux MS, Saunders-Pullman R, Leaver K, Frank S, Pantelyat A, Fung V, Richardson SP, Berman B, Stover N, Deik A, Ondo W, Groth C, Jinnah HA, Shaikh AG. Tremor in cervical dystonia. Dystonia. 2024;3:11309. PMID: 39512809

12.  Williams LJ, Waller S, Qiu J, Innes E, Elserafy N, Procopis P, Sampaio H, Mahant N, Tchan MC, Mohammad SS, Morales-Briceño H, Fung VSC. DHDDS and NUS1: A Converging Pathway and Common Phenotype. Mov Disord Clin Pract. 2024 Jan;11(1):76-85. PMID:38291835

13.  Fealy S, Logan PA, Micalos PS, Rossiter R, Jones D, Irwin P, Schwebel D, Carroll V, Wong A, Fung VSC, Morales-Briceno H, Bramble M. Exploring Parkinson's disease prevalence in regional, rural and remote Australia: A systematic scoping review. Aust J Rural Health. 2023 Dec;31(6):1156-1167. PMID: 37897118

14.  Williams L, Waller SE, Bradley M, Lockhart A, Narayanan RK, Kumar KR, Morales Briceno H, Tchan M, Healy DG, Fung VSC. ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle. Parkinsonism Relat Disord. 2023 Dec;117:105864. PMID: 37827923

15.  Araújo R, Fearon C, Balint B, Bressman S, Friedman J, Jinnah HA, Tijssen MAJ, Lang A, Lees A, Lynch T, Quinn N, Thomson P, Vidailhet M, van de Warrenburg BP, Fung VSC, Bloem BR. The wisdom of our mentors: clinical pearls in movement disorders. Lancet Neurol. 2023 Dec;22(12):1108-1109

16.  Aldred J, Freire-Alvarez E, Amelin AV, Antonini A, Bergmans B, Bergquist F, Bouchard M, Budur K, Carroll C, Chaudhuri KR, Criswell SR, Danielsen EH, Gandor F, Jia J, Kimber TE, Mochizuki H, Robieson WZ, Spiegel AM, Standaert DG, Talapala S, Facheris MF, Fung VSC. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study. Neurol Ther. 2023 Dec;12(6):1937-1958 (Correction published Neurol Ther. 2023 Dec;12(6):1959-1960)

17.  van der Veen S, Tse GTW, Ferretti A, Garone G, Post B, Specchio N, Fung VSC, Trivisano M, Scheffer IE. Movement Disorders in Patients With Genetic Developmental and Epileptic Encephalopathies. Neurology. 2023 Nov 7;101(19):e1884-e1892

18.  Silsby M, Yiannikas C, Fois AF, Ng K, Kiernan MC, Fung VSC, Vucic S. Imbalance and lower limb tremor in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst. 2023 Sep;28(3):415-424

19.  Williams LJ, Qiu J, Tchan M, Morris J, Morales-Briceno H, Fung VSC. Seeing What Is Not There: Revisiting a Diagnostic Conundrum in the Clinic. Mov Disord Clin Pract. 2023 Aug 24;10(Suppl 3):S54-S57

20.  Morales-Briceño H, Ha AD , Chiang H-L, Tai Y-C, Chang F, Tsui D , Griffith J, Galea D, Kim S, Cruse B, Mahant N, Fung VSC.            A single-centre, prospective study of continuous subcutaneous apomorphine infusion, levodopa carbidopa intestinal gel and bilateral subthalamic nucleus deep brain stimulation for Parkinson’s disease. NPJ Parkinsons Dis. 2023 Jun 29;9(1):101

21.  Williams LJ, Qiu J, Ong TL, Deveson IW, Stevanovski I, Chintalaphani SR, Fellner A, Varikatt W, Morales‐Briceno H, Tchan M, Kumar KR. NOTCH2NLC GGC repeat expansion presenting as adult‐onset cervical dystonia. Mov Disord Clin Pract. 2023 Feb 15;10(4):704-706

22.  Waller SE, Williams L, Lee AYS, Lin MW, McCusker E, Morales-Briceño H, Fung VSC. Isolated Craniocervical Dystonia Without Initial Neuropsychiatric Manifestations Associated with NMDA-Receptor Antibodies. Mov Disord Clin Pract. 2022 Aug 9;10(4):680-682

23.  Silsby M, Fois AF, Yiannikas C, Ng K, Kiernan MC, Fung VSC, Vucic S. Chronic inflammatory demyelinating polyradiculoneuropathy-associated tremor: Phenotype and pathogenesis. Eur J Neurol. 2023 Apr;30(4):1059-1068

24.  Dal SR, Lee Ong T, Martin AJ, Halpern JP, Fung VS. A late-onset neurological disorder: is progression inevitable? Parkinsonism Relat Disord. 2023 Mar;108:105092

25.  Vollstedt EJ, Schaake S, Lohmann K, Padmanabhan S, Brice A, Lesage S, …MJFF Global Genetic Parkinson's Disease Study Group. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort. Mov Disord. 2023 Feb;38(2):286-303.

26.  Soileau MJ, Aldred J, Budur K, Fisseha N, Fung VS, Jeong A, Kimber TE, Klos K, Litvan I, O'Neill D, Robieson WZ, Spindler MA, Standaert DG, Talapala S, Vaou EO, Zheng H, Facheris MF, Hauser RA. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. Lancet Neurol. 2022 Dec;21(12):1099-1109

27.  Martin AJ, Ong TL, Briceno-Morales H, Tchan M, Fung VSC. ATP1A3-Related Relapsing Encephalopathy with Cerebellar Ataxia (RECA): A Genetic Disorder with an Inflammatory Basis? Mov Disord Clin Pract. 2022 Sep 30;9(8):1120-1123

28.  Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Ferrazzano G, Wagle-Shukla A, Malaty IA, Jankovic J, Bellows ST, Barbano RL, Vidailhet M, Roze E, Bonnet C, Mahajan A, LeDoux MS, Fung VSC, Chang FCF, Defazio G, Ercoli T, Factor S, Wojno T, Jinnah HA. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022;1:10359. Epub 2022 May 16. PMID:36248010

29.  Williams L, Qiu J, Waller S, Tsui D, Griffith J, Fung VSC. Challenges in managing late-stage Parkinson's disease: Practical approaches and pitfalls. Aust J Gen Pract. 2022 Oct;51(10):778-785

30.  Williams L, Qiu J, Waller S, Tsui D, Griffith J, Fung VS. An approach to acute clinical deterioration in patients with late-stage Parkinson's disease. Aust J Gen Pract. 2022 Aug;51(8):577-583

31.  Morales-Briceno H, Ong TL, Duma SR, Murray N, Pepper EM, Ha A, Tchan MC, Fung VSC. Recurrent Biallelic p.L347P PINK1 Variant in Polynesians with Parkinsonism and Isolated Dopa-Responsive Dystonia. Mov Disord Clin Pract. 2022 Jul 2;9(5):696-697

32.  Morales-Briceño H, Tsui D, Ong TL, Fung VSC, Babu S, Mahant N. Patterns of Beginning of Dose Motor Deterioration: A New Look at an Old Phenomenon. Mov Disord Clin Pract. 2022 Jun 8;9(5):712-716

33.  Waller SE, Williams L, Morales-Briceño H, Fung VS. Teaching Video Neuroimage: Facial-Faucial-Finger Myoclonus in Kufor-Rakeb Syndrome. Neurology. 2022 May 24. PMID:35609988

34.  Fasano A, Fung VSC, Seppi K, Pirtosek Z, Takáts A, Alobaidi A, Onuk K, Bergmann L, Parra JC, Elibol B. Intercountry comparisons of advanced Parkinson's disease symptoms and management: Analysis from the OBSERVE-PD observational study. Acta Neurol Scand. 2022 Aug;146(2):167-176

35.  Fearon C, Rawal S, Olszewska D, Alcaide-Leon P, Kern DS, Sharma S, Jaiswal SK, Murthy JMK, Ha AD, Schwartz RS, Fung VSC, Spears C, Tholanikunnel T, Almeida L, Hatano T, Oji Y, Hattori N, Shubham S, Kumar H, Bhidayasiri R, Laohathai C, Lang AE. Neuroimaging Pearls from the MDS Congress Video Challenge. Part 2: Acquired Disorders. Mov Disord Clin Pract. 2022 Feb 3;9(3):311-325

36.  Grosz BR, Tisch S, Tchan MC, Fung VSC, Darveniza P, Fellner A, Kurian MA, McLean A, Tomlinson SE, Smyth R, Devery S, Wu KHC, Kennerson ML, Kumar KR. A novel synonymous KMT2B variant in a patient with dystonia causes aberrant splicing. Mol Genet Genomic Med. 2022 May;10(5):e1923. PMID:35293157

37.  Williams LJ, Griffith J, Waller SE, Kwan VP, Fung VSC. The Profound Impact of Gastrointestinal Stasis on Levodopa Response in Parkinson's Disease. Mov Disord Clin Pract. 2022 Feb 25;9(3):394-396

38.  Rahman Z, Murray NWG, Sala-Padró J, Bartley M, Dexter M, Fung VSC, Mahant N, Bleasel AF, Wong CH. Investigating the Precise Localization of the Grasping Action in the Mid-Cingulate Cortex and Future Directions. Front Hum Neurosci. 2022 Feb 24;16:815749. doi: 10.3389/fnhum.2022.815749. eCollection 2022. PMID: 35280209

39.  Stevanovski I, Chintalaphani SR, Gamaarachchi H, Ferguson JM, Pineda SS, Scriba CK, Tchan M, Fung V, Ng K, Cortese A, Houlden H, Dobson-Stone C, Fitzpatrick L, Halliday G, Ravenscroft G, Davis MR, Laing NG, Fellner A, Kennerson M, Kumar KR, Deveson IW. Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing. Sci Adv. 2022 Mar 4;8(9):eabm5386. Epub 2022 Mar 4. PMID: 35245110

40.  Waller SE, Morales-Briceño H, Williams L, Mohammad SS, Fellner A, Kumar KR, Tchan M, Fung VSC. Possible EIF2AK2-Associated Stress-Related Neurological Decompensation with Combined Dystonia and Striatal Lesions. Mov Disord Clin Pract. 2021 Dec16;9(2):240-244

41.  Waller S, Williams L, Morales-Briceño H, Fung VS. The initial diagnosis and management of Parkinson's disease. Aust J Gen Pract. 2021 Nov;50(11):793-800

42.  Ong TL, Dal S, Williams LJ, Morales-Briceno H, Fung VSC. Association between Microscopic Colitis and Parkinson's Disease in a Swedish Population. Mov Disord. 2021 Oct;36(10):2452 (letter)

43.  Morales-Briceno H, Fung VSC, Bhatia KP, Balint B. Parkinsonism and dystonia: Clinical spectrum and diagnostic clues. J Neurol Sci. 2021 Oct 1:120016. Online ahead of print. PMID: 34642024

44.  Martin A, Heard R, Fung VSC. Carlos II of Spain, 'The Bewitched': cursed by aspartylglucosaminuria? BMJ Neurol Open. 2021 Sep 27;3(2):e000072. PMID: 34632386

45.  Martin AJ, Ong TL, Babu S, Fung VSC. They Look but Do Not See-Gaze-Evoked Eyelid Spasm. Mov Disord Clin Pract. 2021 Jul 29;8(7):1123-1125

46.  Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter JS, Bäumer T, Usnich T, Berman BD, Mailly M, Roze E, Vidailhet M, Jankovic J, LeDoux MS, Barbano R, Chang FCF, Fung VSC, Pirio Richardson S, Blitzer A, Jinnah HA. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases. Front Neurol. 2021 Sep 16;12:700714. PMID:34603182

47.  Zech M, Kumar KR, Reining S, Reunert J, Tchan M, Riley LG, Drew AP, Adam RJ, Berutti R, Biskup S, Derive N, Bakhtiari S, Jin SC, Kruer MC, Bardakjian T, Gonzalez-Alegre P, Keller Sarmiento IJ, Mencacci NE, Lubbe SJ, Kurian MA, Clot F, Méneret A, de Sainte Agathe JM, Fung VSC, Vidailhet M, Baumann M, Marquardt T, Winkelmann J, Boesch S. Biallelic AOPEP Loss-of-Function Variants Cause Progressive Dystonia with Prominent Limb Involvement. Mov Disord. 2021 Oct 1. PMID:34596301

48.  Fois AF, Mahant N, Vucic S, Fung VSC. Measuring Tremor-A Comparison of Automated Video Analysis, Neurophysiology, and Clinical Rating. Mov Disord. 2021 Sep 2. doi: 10.1002/mds.28776. PMID: 34473360

49.  Silsby M, Yiannikas C, Ng K, Kiernan MC, Fung VSC, Vucic S. Posturography as a biomarker of intravenous immunoglobulin efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 2021 Aug 12. PMID:3438333

50.  Kobuch S, Matar E, Fung VS. Isolated facial nerve palsy following Ixodes holocyclus tick envenomation. Emerg Med Australas. 2021 Aug;33(4):764-766. doi: 10.1111/1742-6723.13811. Epub 2021 Jun 7. PMID: 34096186

51.  Boyce MJ, McCambridge AB, Bradnam LV, Canning CG, Mahant N, Chang FCF, Fung VSC, Verhagen AP. A cross-sectional study of walking, balance and upper limb assessment scales in people with cervical dystonia. J Neural Transm (Vienna). 2021 Jul 31. doi: 10.1007/s00702-021-02388-y. PMID: 34333693

52.  Ong TL, Dal S, Martin AJ, Chang FC, Williams LJ, Babu S, Mahant N, Morales-Briceno H, Fletcher N, Nankervis J, Robbie M, Fung VSC. Levodopa/dopa decarboxylase inhibitor associated microscopic colitis: An under-recognized drug reaction. Parkinsonism Relat Disord. 2021 Apr 20;86:84-90. PMID: 33894560

53.  Fois AF, Chang FC, Barnett R, London K, Mahant N, Ha A, Aldaajani Z, Cruse B, Morales-Briceno H, Ma KK, Farlow D, Fung VS. Rest tremor correlates with reduced contralateral striatal dopamine transporter binding in Parkinson's disease. Parkinsonism Relat Disord. 2021;85:102-108. PMID: 33799200

54.  Waller S, Ong TL, Ibrahim KA, Abdul-Aziz Z, Mahant N, Fung VS. Progressive cognitive decline in two patients with severe MRI brain changes. J Clin Neurosci. 2021 Mar 8:S0967-5868(20)31651-9. doi: 10.1016/j.jocn.2020.11.028. Online ahead of print. PMID: 33707108;

Progressive cognitive decline in two patients with severe MRI brain changes - Answer. J Clin Neurosci. 2021 Mar 8:S0967-5868(21)00043-6. doi: 10.1016/j.jocn.2021.01.034. Online ahead of print. PMID: 33707109

55.  Höglinger GU, Litvan I, Mendonca N, Wang D, Zheng H, Rendenbach-Mueller B, Lon HK, Jin Z, Fisseha N, Budur K, Gold M, Ryman D, Florian H; Arise Investigators. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial. Lancet Neurol. 2021 Mar;20(3):182-192. PMID: 33609476

56.  Thakkar S, Fung VSC, Merola A, Rollins M, Soileau MJ, Kovács N. 24-Hour Levodopa-Carbidopa Intestinal Gel: Clinical Experience and Practical Recommendations. CNS Drugs. 2021 Feb 13. Online ahead of print. PMID: 33582982

57.  Rinaldi S, Davies A, Fehmi J, Beadnall HN, Wang J, Hardy TA, Barnett MH, Broadley SA, Waters P, Reddel SW, Irani SR, Brilot F, Dale RC, Ramanathan S; Australian and New Zealand MOG Study Group. Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders. Neurol Neuroimmunol Neuroinflamm. 2020 Dec 3;8(1):e924. Print 2021 Jan. PMID: 33272955

58.  Evans A, Fung VSC, O'Sullivan JD, Stell R, White R, Williams DR, Femia S, Onuk K. Characteristics of advanced Parkinson's disease patients seen in movement disorder clinics-Australian results from the cross-sectional OBSERVE study. Clinical Parkinsonism & Related Disorders 2021;4:100075 doi.org/10.1016/j.prdoa.2020.100075

59.  Cif L, Demailly D, Lin JP, Barwick KE, Sa M, Abela L, Malhotra S, Chong WK, Steel D, Sanchis-Juan A, Ngoh A, Trump N, Meyer E, Vasques X, Rankin J, Allain MW, Applegate CD, Attaripour Isfahani S, Baleine J, Balint B, Bassetti JA, Baple EL, Bhatia KP, Blanchet C, Burglen L, Cambonie G, Seng EC, Bastaraud SC, Cyprien F, Coubes C, d'Hardemare V; Deciphering Developmental Disorders Study, Doja A, Dorison N, Doummar D, Dy-Hollins ME, Farrelly E, Fitzpatrick DR, Fearon C, Fieg EL, Fogel BL, Forman EB, Fox RG; Genomics England Research Consortium, Gahl WA, Galosi S, Gonzalez V, Graves TD, Gregory A, Hallett M, Hasegawa H, Hayflick SJ, Hamosh A, Hully M, Jansen S, Jeong SY, Krier JB, Krystal S, Kumar KR, Laurencin C, Lee H, Lesca G, François LL, Lynch T, Mahant N, Martinez-Agosto JA, Milesi C, Mills KA, Mondain M, Morales-Briceno H; NIHR BioResource, Ostergaard JR, Pal S, Pallais JC, Pavillard F, Perrigault PF, Petersen AK, Polo G, Poulen G, Rinne T, Roujeau T, Rogers C, Roubertie A, Sahagian M, Schaefer E, Selim L, Selway R, Sharma N, Signer R, Soldatos AG, Stevenson DA, Stewart F, Tchan M; Undiagnosed Diseases Network, Verma IC, de Vries BBA, Wilson JL, Wong DA, Zaitoun R, Zhen D, Znaczko A, Dale RC, de Gusmão CM, Friedman J, Fung VSC, King MD, Mohammad SS, Rohena L, Waugh JL, Toro C, Raymond FL, Topf M, Coubes P, Gorman KM, Kurian MA. KMT2B-related disorders: Expansion of the phenotypic spectrum and long-term efficacy of deep brain stimulation. Brain. 2020 Dec 5;143(11):3242-3261. doi: 10.1093/brain/awaa304. PMID: 33150406

60.  Norris SA, Jinnah HA, Klein C, Jankovic J, Berman BD, Roze E, Mahajan A, Espay AJ, Murthy AV, Fung VSC, LeDoux MS, Chang FCF, Vidailhet M, Testa C, Barbano R, Malaty IA, Bäumer T, Loens S, Wright LJ, Perlmutter JS. Clinical and Demographic Characteristics of Upper Limb Dystonia. Mov Disord. 2020 Aug 26. doi: 10.1002/mds.28223. PMID:32845549

61.  Boyce MJ, Chang FCF, Mahant N, Fung VSC, Bradnam L. A survey of falls in people with dystonia. Physiother Res Int. 2020 Apr 8:e1840. doi: 10.1002/pri.1840. PMID:32267046

62.  Morales-Briceño H, Tsui D, Griffith J, Martin A, Mahant N, Fung VSC. “On-state” freezing of gait: Insights and treatment with levodopa intestinal gel infusion. Mov Disord 2020;35:895-896

63.  Martin AJ, Morales-Briceño H, Tchan M, Fung VSC. The Head Retraction Reflex in Niemann-Pick type C: A Novel Diagnostic Clue. Mov Disord Clin Pract 2020;7(5):543-547. PMID: 32626799

64.  Martin AJ, McGrath R, Fung VSC. A Wilted Flower: Lotus Position Dystonia. Mov Disord Clin Pract 2020 Jan 8;7(2):206-207

65.  Morales-Briceño H, Fung VSC. Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson’s disease. Mov Disord 2020;35(1):81

66.  Kumar KR, Davis RL, Tchan MC, Wali GM, Mahant N, Ng K, Kotschet K, Siow S-F, Gu J, Walls Z, Kang C, Wali G, Levy S, Phua CS, Yiannikas C, Darveniza P, Chang FC, Morales-Briceño H, Rowe DB, Drew A, Gayevskiy V, Cowley M, Minoche A, Tisch S, Hayes M, Kummerfeld S, Fung VS*, Sue CM*. Whole genome sequencing for the genetic diagnosis of heterogenous dystonia phenotypes. Parkinsonism Relat Disord. 2019: Nov 7;69:111-118. [Epub ahead of print] PMID:31731261

67.  Morales-Briceño H, Mohammad SS, Post B, Fois AF, Dale RC, Tchan M, Fung VSC. Clinical and neuroimaging phenotypes of genetic parkinsonism from infancy to adolescence. Brain 2020;143:751-770

68.  Morales-Briceño H, Fung VSC. Is pallidopyramidal syndrome still a useful concept? No. Mov Disord Clin Pract 2019 Oct 14;7(1):27-29

69.  Morales-Briceño H, Mahant N, Ha AD, Chang FCF, Kim SD, Griffith J, Tsui D, Galea D, Fung VSC. Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease. Mov Disord. 2019 Oct 11. [Epub ahead of print] PMID:31603586.

70.  Tea F, Lopez JA, Ramanathan S, Merheb V, Lee FXZ, Zou A, Pilli D, Patrick E, van der Walt A, Monif M, Tantsis EM, Yiu EM, Vucic S, Henderson APD, Fok A, Fraser CL, Lechner-Scott J, Reddel SW, Broadley S, Barnett MH, Brown DA, Lunemann JD, Dale RC, Brilot F; Australasian and New Zealand MOG Study Group. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination. Acta Neuropathol Commun. 2019 Sep 3;7(1):145. doi:10.1186/s40478-019-0786-3. PubMed PMID: 31481127;

71.  Morales-Briceño H, Mahant N, Duma S, Martin A, Tsui D, Griffith J, Fung VSC. Levodopa/carbidopa intestinal gel infusion can improve camptocormia in Parkinson's disease. Parkinsonism Relat Disord 2019 Jun 10. pii: S1353-8020(19)30271-8. [Epub ahead of print] PMID:31221564

72.  Morales-Briceño H, Fung VSC. Gut You shall not pass! Gut bacteria can convert levodopa to dopamine. Mov Disord 2019 Jun 17. doi: 10.1002/mds.27737. [Epub ahead of print] PMID:31206796

73.  Hayes MW, Fung VS, Kimber TE, O’Sullivan JD. Updates and advances in the treatment of Parkinson’s disease. Med J Aust 2019: Jun 16. doi: 10.5694/mja2.50224. [Epub ahead of print] PMID:31203580

74.  Morales-Briceño H, Ha AD, London K, Farlow D, Chang FCF, Fung VSC. Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction. Parkinsonism Relat Disord 2019 doi: 10.1016/j.parkreldis.2019.04.004. [Epub ahead of print] PMID:30975619

75.  Fasano A, Fung VSC, Lopiano L, Elibol B, Smolentseva IG, Seppi K, Takáts A, Onuk K, Parra JC, Bergmann L, Sail K, Jalundhwala Y, Pirtosek Z. Characterizing advanced Parkinson’s disease: OBSERVE-PD observational study results of 2615 patients BMC Neurology 2019:Apr 2;19(1):50. doi: 10.1186/s12883-019-1276-8

76.  Silsby M, Duma SR, Fois AF, Yin YWK, Koryzna J, Mahant N, Evans A, Fung VSC. Time to acute stroke treatment in-hours was more than halved after the introduction of the Helsinki model at Westmead Hospital. Intern Med J. 2019 Mar 19. [Epub ahead of print] PMID:30887620

77.  Morales-Briceño H, Renan Perez J, Balint B, Fung VSC. Cold induced laryngeal pseudomyotonia in Isaacs' syndrome. Neurology 2019:Jun 4;92(23):e2734

78.  Duma SR, Fung VSC. Drug-induced movement disorders. (Review) Australian Prescriber 2019 Apr;42(2):56-61

79.  Morales-Briceño H, Fung V. Author response: IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple disease. Neurology 2019;92:544-545

80.  Cruse B, Morales-Briceño H, Chang FCF, Mahant N, Ha AD, Kim SD, Wolfe N, Kwan V, Tsui DS, Griffith JM, Galea D, Fung VSC. 24-hour levodopa-carbidopa intestinal gel may reduce troublesome dyskinesia in advanced Parkinson’s disease. (Nature partnership journals) npj Parkinsons Dis 2018: 10.1038/s41531-018-0070-4

81.  Morales-Briceño H, Chang FCF, Wong C Mallawaarachchi A, Wolfe N, Pellegrino da Silva R,  Hakon H. Sandaradura S, Guo Y, Christodoulou J, Fung VSC. Paroxysmal dyskinesias with drowsiness and thalamic lesions in GABA transaminase deficiency. Neurology 2019;92(2):94-97

82.  Pelicioni PHS, Brodie MA, Latt MD, Menant JC, Menz HB, Fung VSC, Lord SR. Head and trunk stability during gait before and after levodopa intake in Parkinson's disease subtypes. Exp Gerontol. 2018 Jul 3;111:78-85

83.  Morales-Briceño H, Cruse B, Fois AF, Lin M-W, Jiang J, Banerjee D, Grunstein R, Varikatt W, Rodriguez M, Shepherd C, Fung VSC. IgLON5-mediated neurodegeneration is a differential diagnosis of CNS Whipple’s disease. Neurology 2018 Jun 12;90(24):1113-1115 (May 16 Epub ahead of print)

84.  Fernandez HH, Boyd JT, Fung VSC, Lew MF, Rodriguez RL, Slevin JT, Standaert DG, Zadikoff C, Vanagunas AD, Chatamra K, Eaton S, Facheris MF, Hall C, Robieson WZ, Benesh J, Espay AJ. Long-term safety and efficacy of levodopa-carbidopa intestinal gel in advanced Parkinson's disease. Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27338. [Epub ahead of print]

85.  Anna Planas-Ballvé, Hugo Morales-Briceño, Ane Miren Crespo-Cuevas, Victor SC Fung. Movement disorders and spinal cord atrophy in Cockayne syndrome with prolonged survival. Mov Disord Clin Pract 2017 DOI: 10.1002/mdc3.12588

86.  Hugo Morales-Briceño, Beatriz E Sanchez-Hernandez, Esther Meyer, Manju A Kurian, Alessandro F Fois, Mayela Rodriguez-Violante, Roberto Leal-Ortega, Christian Perez-Lohman, Shekeeb Mohammad, Victor S.C Fung. Beta Propeller Associated Neurodegeneration can present with dominant or isolated Parkinsonism. Mov Disord 2018 Apr;33(4):654-656

87.  Ramanathan S, Mohammad S, Tantsis E, Nguyen TK, Merheb V, Fung VSC, White OB, Broadley S, Lechner-Scott J, Vucic S, Henderson APD, Barnett MH, Reddel SW, Brilot F, Dale RC; Australasian and New Zealand MOG Study Group. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination. J Neurol Neurosurg Psychiatry. 2018 Feb;89(2):127-137

88.  Boyce MJ, Lam L, Chang F, Mahant N, Fung VSC, Bradnam L. Validation of Fear of Falling and Balance Confidence Assessment Scales in Persons With Dystonia. J Neurol Phys Ther. 2017 Oct;41(4):239-244.

89.  Morales-Briceño H, Fung VS. Isolated nocturnal occurrence of orofacial dyskinesias in NMDA receptor encephalitis – A new diagnostic clue. Mov Disord Clin Pract 2017;4:884–88

90.  Forsyth AL, Paul SS, Allen NE, Sherrington C, Fung VS, Canning CG. Flexed truncal posture in Parkinson's disease: measurement reliability and relationship with physical and cognitive impairments, mobility and balance. J Neurol Phys Ther. 2017 Mar 3. doi: 10.1097/NPT.0000000000000171. [Epub ahead of print] PMID:28263252

91.  Williams DR, Evans AH, Fung VS, Hayes M, Iansek R, Kimber T, O'Sullivan JD, Sue CM. Practical approaches to commencing device-assisted therapies for Parkinson's disease in Australia. Intern Med J. 2017 Feb 14. doi: 10.1111/imj.13398. [Epub ahead of print]. PMID:28195385

92.  Chiang H-L, Tai Y-C, McMaster J, Fung VSC, Mahant N. Primary orthostatic tremor: Is Deep Brain Stimulation better than spinal cord stimulation? J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):804-805

93.  Pirio Richardson S, Wegele AR, Skipper B, Deligtisch A, Jinnah HA; Dystonia Coalition Investigators. Dystonia treatment: Patterns of medication use in an international cohort. Neurology. 2017 Jan 11. pii: 10.1212/WNL.0000000000003596. doi: 10.1212/WNL.0000000000003596. [Epub ahead of print] PMID:28077492

94.  Fung VS, Chang FC, Westenberger A, Klein C. Reply letter to "ADCY5-related dyskinesia: Comments on characteristic manifestations and variant-associated

severity". Mov Disord. 2016 Dec 1. doi: 10.1002/mds.26881. [Epub ahead of print]

PMID: 27905127.

95.  Cao Y, Menon P, Chang FCF, Mahant N, Geevasinga N, Fung VSC, Vucic S. Postural tremor and chronic inflammatory demyelinating polyneuropathy. Muscle and Nerve 2016 Jul 16. doi: 10.1002/mus.25253. [Epub ahead of print] PMID:27421831

96.  Kim H-J, Jeon B, Fung VSC. Role of MRI in the diagnosis of multiple system atrophy. Mov Disord Clin Pract 2017;4:12-20 (JUL 2016 | DOI: 10.1002/mdc3.12404)

97.  Menon S, Muglan JA, Shimon L, Stewart D, Snow B, Hayes M, Fung VS, Jog MS. Down the stairs dystonia – A novel task specific, focal isolated syndrome. Mov Disord Clin Pract 2017;4:121-124 (6 JUN 2016, DOI: 10.1002/mdc3.12371)

98.  Tai Y-C, Yin YWK, Ha AD, Adam R, Mahant N, Sue CM, Fung VSC. Neurophysiological Features of Hemiballism. Mov Disord Clin Pract 2017;4:116-120 (19 MAY 2016, DOI: 10.1002/mdc3.12356)

99.  Dy ME, Chang FCF, De Jesus S, Anselm I, Mahant N, Zeilman P, Rodan LH, Foote KD, TanW-H, Eskandar E, Sharma N, Okun MS, Fung VSC, Waugh JL. Treatment of movement disorders in ADCY5-related disorders with deep brain stimulation: a case series. J Child Neurol. 2016 Apr 6. pii: 0883073816635749. [Epub ahead of print] PMID:27052971

100. Chang FCF, Ana Westenberger A, Dale RC, Smith M, Pall HS, Perez-Dueñas B, Grattan-Smith P, Ouvrier RA, Mahant N, Hanna BC, Hunter M, Lawson JA, Max C, Rani Sachdev R, Meyer E, Crimmins D, Pryor D, Morris JGL, Münchau A, Grozeva D, Carss KJ, Raymond L, Kurian MA, Klein C, Fung VSC. Phenotypic insights into ADCY5-associated disease.  Mov Disord 2016 Apr 8. doi: 10.1002/mds.26598. [Epub ahead of print] PMID:27061943

101.   Aldaajani Z, Chang FCF, Kim SD, Mahant N, Fung VSC. Orthostatic myoclonus: A report of four cases. J Clin Neurosci 2016 Feb 22. pii: S0967-5868(16)00049-7. doi: 10.1016/j.jocn.2015.12.026. [Epub ahead of print]PMID:26916904

102.   Antonini A, Fung VSC, Boyd JT, Slevin JT, Hall C, Chatamra K, Eaton S, Benesh JA. Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients. Mov Disord 2016 doi: 10.1002/mds.26528

103.   Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group. Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke. Neurology. 2016 Jan 12;86(2):118-25.

104.   Tai Y-C, Fog M, Fung VSC. Phenomenology: clonic perseveration or stereotypy? JAMA Neurology 2015 Dec 28:1. doi: 10.1001/jamaneurol.2015.3921. [Epub ahead of print] (Letter)

105.   Lang AE, Rodriguez RL, Boyd JT, Chouinard S, Zadikoff C, Espay AJ, Slevin JT, Fernandez HH, Lew MF, Stein DA, Odin P, Fung VS, Klostermann F, Fasano A, Draganov PV, Schmulewitz N, Robieson WZ, Eaton S, Chatamra K, Benesh JA, Dubow J. Integrated safety of levodopa-carbidopa intestinal gel from prospective clinical trials. Mov Disord. 2015 Dec 23. doi: 10.1002/mds.26485. [Epub ahead of print] PMID:26695437

106.   Raj Kumar K, Fung VS. ADCY5 identified as a novel cause of benign hereditary chorea. Mov Disord. 2015 Nov;30(13):1726. doi: 10.1002/mds.26434. Epub 2015 Sep 26.

107.   Farag I, Sherrington C, Hayes A, Canning CG, Lord SR, Close JC, Fung VS, Howard K. Economic evaluation of a falls prevention exercise program among people with Parkinson's disease. Mov Disord. 2015 Sep 23. doi: 10.1002/mds.26420. [Epub ahead of print] PMID: 26395438

108.   Ramanathan S, Prelog K, Barnes E, Tantsis E, Reddel SW, Henderson A, Vucic S, Gorman MP, Benson L, Alper G, Riney CJ, Barnett M, Parratt JDE, Hardy T, Leventer R, Merheb V, Nosadini M, Fung VSC, Brilot F, Dale RC. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler 2015 2015 Jul 10. pii: 1352458515593406. [Epub ahead of print] PMID:26163068

109.   Chang FCF, Kwan V, van der Poorten D, Mahant N, Wolfe N, Ha SD, Griffith JM, Tsui D, Kim SD, Fung VSC. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson’s disease. J Clin Neurosci 2016;25:41-5. doi: 10.1016/j.jocn.2015.05.059. Epub 2016 Jan 14.

110.   Allen NE, Song J, Paul SS, Sherrington C, Murray SM, O’Rourke SD, Lord SR, Fung VSC, Close JCT, Howard K, Canning CG. Predictors of adherence to a falls prevention exercise program for people with Parkinson’s disease. Mov Disord Clin Pract 2015;2:395–401

111.   Lew MF, Slevinb JT, Krüger R, Martínez Castrillo JC, Chatamrae K, Dubowf JS, Robiesone WZ, Beneshe JA, Fung VSC Initiation and dose optimization for levodopa-carbidopa intestinal gel: Insights from phase 3 clinical trials. Parkinsonism Relat Disord. 2015;21:742-8. doi: 10.1016/j.parkreldis.2015.04.022. Epub 2015 Apr 28. PMID:25962554

112.   Ramanathan S, Fung VSC, Bielich A, Masters L, Russo RR, Buckland ME, Sarros S, Klug GM, Collins S, Reddel S. Hyperekplexia as the presenting symptom of Creutzfeldt-Jakob Disease. Neurology Clinical Practice 2015 (accepted)

113.   Fung VSC. New and emerging treatments for Parkinson disease. (Editorial) Med J Aust 2015;202(6):283-4

114.   McCann H, Fung VSC, Klein C, Halliday GM. Unique cerebellar and α-synuclein pathology in hereditary myoclonus-dystonia. Neuropathol Appl Neurobiol. 2015 Jan 13. doi: 10.1111/nan.12216. [Epub ahead of print] PMID:25582306

115.   Chang FCF, Tsui DS, Mahant N, Wolfe N, Kim SD, Ha AD, Drury M, Griffith JM, Fung VSC. 24 hour levodopa-carbidopa intestinal gel may reduce falls and “unresponsive” freezing of gait in Parkinson’s disease. Parkinsonism Relat Disord. 2015 Mar;21(3):317-20. doi: 10.1016/j.parkreldis.2014.12.019. Epub 2014 Dec 26. PMID:25578290  

116.   Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VSC, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Levodopa-carbidopa intestinal gel in advanced Parkinson disease: Final 12-month, open-label results. Movement Disorders 2015 Apr;30(4):500-9. doi: 10.1002/mds.26123. Epub 2014 Dec 24. PMID:25545465

117.   Canning C, Sherrington C, Lord S, Close J, Heritier S, Heller G, Howard K, Allen N, Latt MD, Murray S, O'Rourke S, Paul S, Song J, Fung VSC. Exercise for falls prevention in Parkinson’s disease: a randomized controlled trial. Neurology 2015 Jan 20;84:304-12. doi: 10.1212/WNL.0000000000001155. Epub 2014 Dec 31. PMID:25552576

118.   Paul SS, Allen NE, Sherrington C, Heller G, Fung VSC, Close JCT, Lord SR, Canning CG. Risk factors for frequent falls in people with Parkinson’s disease. J Parkinsons Dis 2014;4(4):699-703. doi: 10.3233/JPD-140438

119.   Ramanathan S, Reddel SW, Henderson A, Parratt JDE, Barnett M, Gatt PN, Merheb V, Kumaran R-Ya, Pathmanandavel K, Sinmaz N, Ghadiri M, Yiannikas C, Vucic S, Stewart G, Bleasel AF, Booth D, Fung VSC, Dale RC, Brilot F. Antibodies to myelin oligodendrocyte glycoprotein in bilateral and recurrent optic neuritis. Neurol Neuroimmunol Neuroinflamm. 2014 Oct 29;1(4):e40. doi: 10.1212/NXI.0000000000000040 PMID:25364774

120.   Chang FCF, Fung VSC. Clinical significance of pharmacogenomics studies in Tardive Dyskinesia (TD) associated with patients with psychiatric disorders. Pharmgenomics Pers Med 2014 Oct 13;7:317-28. doi: 10.2147/PGPM.S52806. PMID:25378945

121.   Mohammad SS, Fung VSC, Grattan-Smith P, Gill D, Pillai S, Ramanathan S, Brilot F, Dale RC. Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies.  Mov Disord 2014;29:1539-42. doi: 10.1002/mds.25999. Epub 2014 Aug 22

122.   Kim SD, Fung VSC. An update on Huntington's disease: from the gene to the clinic. Curr Opin Neurol. 2014 Aug;27(4):477-83

123.   Adam RJ, McLeod R, Ha AD, Colebatch J, Menzies G, de Moore G, Fung VSC, Mahant N.  Resolution of Othello syndrome following subthalamic nucleus deep brain stimulation in 3 patients with Parkinson's Disease. Mov Disord Clin Pract 2014;1:357–360

124.   Balint B, Mahant N, Meinck H-M, Fung VSC. Stiff Limb Syndrome mimicking Corticobasal Syndrome. Mov Disord Clin Pract 2014;1:354–356

125.   Fung VSC. Diagnosis on Shaky Grounds. (Editorial). J Neurol Neurosurg Psychiatr 2014 Sep;85(9):947-8; 2013 Nov 22. doi: 10.1136/jnnp-2013-306538.

126.   Ramanathan S, Bleasel A, Parratt J, Orr C, Dale RC, Vincent A, Fung VSC. Characterisation of a syndrome of autoimmune adult onset focal epilepsy and encephalitis. J Clin Neurosci 2013 Dec 12 doi:10.1016/j.jocn.2013.09.024. [Epub ahead of print]  2014 Jul;21(7):1169-75

127.   Kim SD,Yiannikas C, Mahant N, Vucic S, Fung VSC. Treatment of proximal upper limb tremor with botulinum toxin therapy. Mov Disord 2013 Nov 20. doi: 10.1002/mds.25739. [Epub ahead of print] 2014 May;29(6):835-8

128.   Paul SS, Canning CG, Song J, Fung VSC, Sherrington C. Leg muscle power is enhanced by training in people with Parkinson's disease: a randomised controlled trial. Clin Rehab 2014;28:275 –288 [2013 Nov 4. Epub ahead of print] PMID:24188914

129.   Ha AD, Parratt JD, Babu S, Kim SD, Mahant N, O’Neill J, Halpern J-P, Fung VSC. Movement Disorders Associated with CLIPPERS. (Letter). Mov Disord 2014;29:148-50 [2013 Nov 12. doi: 10.1002/mds.25719.  Epub ahead of print] PMID:24222187

130.   Paul SS, Sherrington C, Canning CG, Fung VSC, Close JCT, Lord SR. The relative contribution of physical and cognitive fall risk factors in people with Parkinson’s disease: a large prospective cohort study. Neurorehabil Neural Repair 2013 Nov 15. [Epub ahead of print] PMID:24243915; 2014 Mar-Apr;28(3):282-90

131.   Kemp S, Harding AJ, Halliday GM, Mahant N, Fung VSC. Cortical limb myoclonus in pathologically proven progressive supranuclear palsy. Mov Disord 2013 Oct 4. doi:10.1002/mds.25693. [Epub ahead of print] 2013 Nov;28(13):1804-6

132.   Phu AL, Xu Z, Brakoulias V, Fung VSC, Mahant N, De Moore G, Martin A, Starcevic V, Krause M. Effect of Impulse Control Disorders on disability and quality of life in Parkinson’s Disease. J Clin Neurosci 2013 Sep 10. doi:pii: S0967-5868(13)00249-X. 10.1016/j.jocn.2013.02.032. [Epub ahead of print] 2014 Jan;21(1):63-6

133.   Fung VSC, Jinnah HA, Bhatia K, Vidailhet M. Assessment of the patient with isolated or combined dystonia: an update on dystonia syndromes. Mov Disord 2013;28: 889-898

134.   LeWitt PA, Boroojerdi B, Surmann E, Poewe W; SP716 Study Group; SP715 Study Group. Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER. J Neural Transm. 2013 Jul;120(7):1069-81.

135.   Trinh B, Ha AD, Mahant N, Kim SD, Owler B, Fung VSC. Dramatic Improvement of Truncal Tardive Dystonia Following GPi DBS.  J Clin Neurosci. 2014 Mar;21(3):515-7 [EPub 2013 Jun 18. doi:pii: S0967-5868(13)00311-1. 10.1016/j.jocn.2013.03.03]

136.   Ramanathan S, Wong CH, Fung VSC. Long duration between presentation of probable anti-NMDAR encephalitis and either clinical relapse or positive serum autoantibodies . J Clin Neurosci 2013 Sep;20(9):1322-3 [2013 Mar 23. Epub ahead of print] DOI:s10.1016/j.jocn.2012.10.023

137.   Paul SS, Canning CG, Sherrington C, Lord SR, Close JCT, Fung VSC. Three simple clinical tests to accurately predict falls in people with Parkinson’s disease. Mov Disord 2013 Feb 28. [Epub ahead of print] PMID: 23450694

138.   Kim SD, Allen NE, Canning CG, Fung VSC. Postural Instability in Patients with Parkinson's Disease: Epidemiology, Pathophysiology and Management. CNS Drugs 2013 Feb;27(2):97-112 [2012 Oct 18. Epub ahead of print] PMID:23076544

139.   Boyce MJ, Canning CG, Mahant N, Morris J, Latimer J, Fung VSC. Active exercise for individuals with cervical dystonia: a pilot randomized controlled trial. Clin Rehab 2013 Mar;27(3):226-35 [2012 Aug 17. Epub ahead of print] PMID:22904115

140.   Ha AD, Fung VSC. Huntington's Disease. Curr Opin Neurol 2012;25(4):491-8

141.   Ha AD, Parratt KL, Rendtorff  ND, Lodahl M, Ng K, Rowe DB, Sue CM, Hayes MW, Tranebjærg L, Fung VSC. The phenotypic spectrum of dystonia in Mohr-Tranebjaerg syndrome. Mov Disord 2012;27:1034-40

142.   Paul SS, Canning CG, Sherrington C, Fung VSC. Reduced muscle strength is the major determinant of reduced leg muscle power in Parkinson's disease. Parkinsonism Relat Disord 2012 Jun 8. [Epub ahead of print] PMID: 22682756

143.   IST-3 collaborative group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet. 2012 Jun 23;379(9834):2352-63

144.   Paul SS, Canning CG, Sherrington C, Fung VSC. Reproducibility of measures of leg muscle power, leg muscle strength, postural sway and mobility in people with Parkinson's disease. Gait and Posture 2012 May 26. [Epub ahead of print] PMID:22640867

145.   Paul SS, Sherrington C, Fung VSC, Canning CG. Motor and cognitive impairments in Parkinson's disease: relationships with specific balance and mobility tasks. Neurorehabil Neural Repair 2012 May 23. [Epub ahead of print] PMID:22623207

146.   Kim SD, Vucic S, Mahant N, Kiernan MC, Fung VSC. The relationship between cortical and spinal hyperexcitability and clinical disease severity in stiff-man syndrome. Parkinsonism Relat Disord. 2012 May 11. [Epub ahead of print] PMID: 22579814

147.   Boyce MJ, Canning CG, Mahant N, Morris J, Latimer J, Fung VSC. The Toronto Western Spasmodic Torticollis Rating Scale: reliability in neurologists and physiotherapists. Parkinsonism Relat Disord 2012 Jun;18(5):635-7

148.   Kemp S, Kim SDH, Cordato DJ, Fung VSC. Delayed-onset focal dystonia of the leg secondary to traumatic brain injury. J Clin Neurosci. 2012;19(6):916-7

149.   Canning CG, Allen NE, Dean CM, Goh L, Fung VSC. Home-based treadmill training for individuals with Parkinson’s disease: a randomized controlled pilot trial. Clin Rehabil. 2012;26(9):817-26

150.   Chang FCF, Mehta P, Koentjoro B, Latt M, Blair N, Nicholson G, Sue CM, Fung VSC. Dancing feet dyskinesias”: a clue to parkin gene mutations. Mov Disord 2012;4:587-8

151.   Dale R, Grattan-Smith P, Fung VSC, Peters GB. Infantile convulsions and paroxysmal kinesigenic dyskinesia with 16p11.2 microdeletion. Neurology 2011;77:1401-2

152.   Park JS, Mehta P, Cooper AA, Veivers D, Heimbach A, Stiller B, Kubisch C, Fung VS, Krainc D, Mackay-Sim A, Sue CM. Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb Syndrome, a form of early-onset Parkinsonism. Hum Mutat 2011;32:956-64

153.   Sandercock P, Lindley R, Wardlaw J, Dennis M, Innes K, Cohen G, Whiteley W, Perry D, Soosay V, Buchanan D, Venables G, Czlonkowska A, Kobayashi A, Berge E, Slot KB, Murray V, Peeters A, Hankey GJ, Matz K, Brainin M, Ricci S, Cantisani TA, Gubitz G, Phillips SJ, Antonio A, Correia M, Lyrer P, Kane I, Lundstrom E; IST-3 collaborative group. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. Trials. 2011 Nov 30;12:252

154.   Krause M, Mahant N, Kotschet K, Fung VS, Vagg D, Wong CH, Morris JG. Dysexecutive behaviour following deep brain lesions - a different type of disconnection syndrome? Cortex 2012;48:97-119 (2011 Mar 31. PMID:21546014 [Epub ahead of print])

155.   Ramanathan S, McMeniman J, Cabela R, Holmes-Walker DJ, Fung VSC. SIADH and Dysautonomia as the Initial Presentation of Guillain-Barre Syndrome. J Neurol Neurosurg Psychiatr 2012;83:344-5 (2011 Feb 18. PMID:21335571 [Epub ahead of print])

156.   Menant JC, Latt MD, Menz HB, Fung VS, Lord SR. Postural sway approaches centre of mass stability limits in Parkinson’s disease. Mov Disord 2011;26:637-43

157.   Tuck KK, Yeow TC, Morris JGL, Baker F, Fung VSC. Using the Fogs’ Test to assess Associated Movements in Parkinsonism, Dystonia and Controls. Mov Disord 2011;26:121-4

158.     Chang FCF, Berman Y, Buckland ME, MacKinlay N, Ng K. Genetic prion disease associated myelodysplasia and SIADH in siblings. European Journal of Neurology, Volume 18, Issue 12, pages, e149-150, December 2011.

159.   Allen NE, Canning CG, Sherrington C, Lord SR, Latt MD, Close JCT, O’Rourke SD, Murray SM, Fung VSC. The effects of an exercise program on fall risk factors in people with Parkinson's disease: A randomized controlled trial Mov Disord 2010;25:1217-25

160.   Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O’Sullivan JD, Fung VSC, Smith RAJ, Murphy MP, Taylor KM on behalf of the Protect Study Group. A Double-Blind, Placebo-Controlled Study to Assess the Mitochondria-Targeted Antioxidant MitoQ as a Disease Modifying Therapy in Parkinson’s disease. Mov Disord 2010;25:1670-4

161.   Dale RC, Melchers A, Fung VSC, Grattan-Smith P, Houlden H, Earl J. Familial dopa-responsive paroxysmal exercise-induced dystonia and restless legs syndrome due to GTP-cyclohydrolase 1 mutation. Dev Med Child Neurol 2010;52:583-6

162.   Allen NE, Sherrington C, Canning CG, Fung VSC. Reduced muscle power is associated with slower walking velocity and falls in people with Parkinson's disease. Parkinsonism Relat Disord 2010;16:261-4

163.   Hayes MW, Fung VS, Kimber TE, O’Sullivan JD. Current concepts in the management of Parkinson's disease. (Review). Med J Aust 2010;192:144-9

164.   Allen NE, Canning CG, Sherrington C, Fung VSC. Bradykinesia, muscle weakness and reduced muscle power in Parkinson’s disease. Mov Disord 2009;24:1344-51

165.   Latt MD, Lord SR, Morris JGL, Fung VSC. Clinical and physiological assessments for elucidating falls risk in Parkinson’s disease. Mov Disord 2009 Jul 15;24:1280-9

166.   Mevawalla N, Fung VSC, Morris JGL, Halliday G. Rest tremor in vascular parkinsonism associated with a contralateral lesion of the locus coeruleus. Mov Disord 2009;24:1242-4

167.   Lindley RI, Wang JJ, Wong M-C, Mitchell P, Liew G, Hand P, Wardlaw J, De Silva D, Baker M, Rochtchina E, Chen C, Hankey GJ, Chang H-M, Fung VS, Gomes L,Wong TY. Retinal Microvascular Changes in Acute Lacunar Stroke. Lancet Neurology 2009;8:628-634

168.   Double KL, Rowe DB, Carew-Jones FM, Hayes M, Chan DK, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Riederer P, Gerlach M, Halliday GM. Anti-melanin antibodies are increased in sera in Parkinson's disease. Exp Neurol. 2009;217:297-301

169.   Latt MD, Menz HB, Fung VS, Lord SR. Acceleration Patterns of the Head and Pelvis During Gait in Older People With Parkinson's Disease: A Comparison of Fallers and Nonfallers. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2009;64:700-6

170.   Exercise therapy for prevention of falls in people with Parkinson's disease: A protocol for a randomised controlled trial and economic evaluation. Canning CG, Sherrington C, Lord SR, Fung VS, Close JC, Latt MD, Howard K, Allen NE, O'Rourke SD, Murray SM. BMC Neurol. 2009 Jan 22;9(1):4

171.   Fung VSC, Herawati L, Wan Y, Movement Disorder Society of Australia Clinical Research and Trials Group, on behalf of the QUEST-AP Study Group. Quality of life in early Parkinson’s disease treated with levodopa/carbidopa/entacapone. Mov Disord 2009:24:25-31

172.   Lindley RI, Multi-Centre Retinal Stroke Study Collaborative Group. Retinal microvascular signs: A key to understanding the underlying pathophysiology of different stroke subtypes? Int J Stroke 2008;3:297-305 (Member of Writing Committee & Grantholder)

173.   SCOPE (Stroke Complications and Outcomes Prediction Engine) Collaborations; IST, Lewis SC, Sandercock PA, Dennis MS. Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3). J Neurol Neurosurg Psychiatry 2008;79:397-400.

174.   Sharma NS, Ooi J-L, Papalkar D, Sharma S, Francis IC, Fung VSC. Pharmacological mydriasis secondary to ipratropium bromide: A cause of unilateral dilated pupil. J Clin Neurosci 2008;15:320–321

175.   Grünewald A, Djarmati A, Lohmann-Hedrich K, Farrell K, Zeller JA, Allert N, Papengut F, Petersen B, Fung V, Sue CM, O'Sullivan D, Mahant N, Kupsch A, Chuang RS, Wiegers K, Pawlack H, Hagenah J, Ozelius LJ, Stephani U, Schuit R, Lang AE, Volkmann J, Münchau A, Klein C. Myoclonus-dystonia case series: Significance of large SGCE deletions. Hum Mutat 2008;29:331-2

176.   Latt MD, Menz HB, Fung VS, Lord SR. Walking speed, cadence and step length are selected to optimize the stability of  head and pelvis accelerations. Exp Brain Res. 2008;184:201-9

177.   Huang Y, Hayes M, Harding AJ, Brooks WS, Fung VSC, Rowe D, Joffe R, Crimmins D, Hely M, Halliday GM. Anticipation of onset age in familial Parkinson's disease without SCA gene mutations. Parkinsonism & Related Disorders 2006;12:309-13

178.   Kipps CM, Fung VSC, Grattan-Smith P, Demoore GM, Morris JG. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal. (Reply). Mov Disord. 2005 Dec;20(12):1671-2

179.   Bacsi AM, Fung VSC, Colebatch JG. Sway patterns in orthostatic tremor: impairment of postural control mechanisms. Mov Disord 2005 Nov;20(11):1469-75

180.   M Perrin, DJ Cordato, VSC Fung, D Wong. Acute and reversible micrographia in a patient with cerebral ischemia. J Clin Neurosci 2005;12:329-31.

181.   Kipps CM, Fung VSC, Grattan-Smith P, deMoore G, Morris JGL. Movement Disorder Emergencies (Review). Mov Disord 2005;20:322-34

182.   Henderson J, Rodriguez M, O'Sullivan D, Pell M, Fung V, Benabid AL, Halliday G. Partial lesion of thalamic ventral intermediate nucleus after chronic high-frequency stimulation. Mov Disord 2004;19:709-11.

183.   Double KL, Rowe DB, Hayes M, Chan DKY, Blackie J, Corbett A, Joffe R, Fung VS, Morris J, Halliday GM. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test Arch Neurol 2003;60:545-9.

184.   Mahant N, Cordato DJ, Fung VSC. Focal myoclonus-dystonia of the leg secondary to a lesion of the posterolateral putamen: clinical and neurophysiological features. Mov Disord 2003;18:452-455.

185.   Mahant N, Fung VSC, Morris JGL. Managing Parkinson’s Disease. (Review) Medicine Today 2003;4:16-22

186.   Lang EW, Neugebauer M, Ng K, Fung V, Clouston P, Dorsch NWC. Facial nerve palsy after intracisternal papaverine application during aneurysm surgery. Neurologia Medico-Chirurgica 2002;42:565-567

187.   Morris JGL, Jankelowitz SK, Fung VSC, Clouston PD, Hayes MW, Grattan-Smith P. Athetosis I: Historical considerations. Mov Disord 2002;17:1278-1280

188.   Morris JGL, Grattan-Smith P, Jankelowitz SK, Fung VSC, Clouston PD, Hayes MW. Athetosis II: The syndrome of mild athetoid cerebral palsy. Mov Disord 2002;17:1281-1287

189.   Fung VSC, Morris JGL, Pell M. Surgical Treatment of Parkinson’s Disease. (Editorial) Med J Aust 2002;177:125-126

190.   Burne JA, Hayes MW, Fung VSC, Yiannikas C, Boljevac D. The contribution of tremor studies to diagnosis of Parkinsonian and essential tremor: a statistical evaluation. J Clin Neurosci. 2002;9:237-42.

191.   Grattan-Smith PJ, Wevers RA, Steenbergen-Spanjers GC, Fung VS, Earl J, Wilcken B. Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy. Mov Disord. 2002;17:354-9

192.   Henderson JM, Pell M, O'Sullivan DJ, McCusker EA, Fung VS, Hedges P, Halliday GM. Post-mortem analysis of bilateral subthalamic electrode implants in Parkinson's disease. Mov Disord. 2002;17:133-7

193.   Fung VSC, Hely MA, Morris JGL. Treatment of Parkinson’s disease. (Review) Australian Prescriber 2001;24:92-95

194.   Henderson JM, O'Sullivan DJ, Pell M, Fung VSC, Hely MA, Morris JGL, Halliday GM. Lesion of thalamic centromedian-parafascicular complex after chronic deep brain stimulation. Neurology 2001;56:1576-1579.

195.   Hely MA, Fung VSC, Morris JGL. Treatment of Parkinson’s disease. (Review) J Clin Neurosci 2000;7:484-494

196.   Fung VSC, Duggins A, Morris JGL, Lorentz IT. Progressive myoclonic ataxia associated with coeliac disease presenting as unilateral cortical tremor and dystonia. Mov Disord. 2000;15:732-734

197.   Ellaway CJ, Duggins A, Fung VS, Earl JW, Kamath R, Parsons PG, Antony JA, North KN. Cockayne Syndrome associated with low CSF 5-hydroxyindole acetic acid levels. J Med Genet 2000;37:553-557

198.   Fung VSC, Sue CM, Somerville ES. Paroxysmal word deafness secondary to focal epilepsy. Neurology 2000;54:533-534

199.   Fung VSC, Burne JA, Morris JGL. Objective quantification of resting and activated Parkinsonian rigidity: a comparison of angular impulse and work measurements. Mov Disord. 2000;15:48-55

200.   Friend K, Crimmins D, Phan TG, Sue CM, Collie A, Fung VSC, Morris JGL, Sutherland GR, Richards RI. Detection of a novel missense mutation and second recurrent mutation in the CaCna1a gene in individuals with EA2 and FHM. Hum Mut 1999;105:261-265

201.   Fung VSC , Yiannikas C, Sue CM, Yiannikas J, Herkes GK, Crimmins DS. Is Sydenham's chorea an antiphospholipid syndrome? A report of three cases and review of the literature. J Clin Neurosci 1998;5:115-118

202.   Fung VSC, Morris JGL, Leicester J, Soo YS , Davies L. Clonic perseveration following thalamo-frontal disconnection: a distinctive movement disorder. Mov Disord. 1997;12:378-385

203.   Fung VSC, Walker GL, Yiannikas C. Nonsystemic vasculitic neuropathy presenting as progressive paraplegia. (Letter) Muscle and Nerve 1997;20:766-767

204.   Sue CM, Fung V, Halpern JP, Boyages SC, Yiannikas C. Hashimoto’s encephalopathy. J Clin Neurosci 1997;4:74-77

205. Clouston PD, Lim CL, Fung V, Yiannikas C, Morris JGL. Brainstem myoclonus in a patient with non-dopa-responsive Parkinsonism. Mov Disord. 1996;11:404-410

206. Chang FCF, Frucht SJ. Motor and sensory dysfunction in musician’s dystonia. Current Neuropharmacology. Volume 11, Issue 1, page 41-47, 2013 January.

207. Chang FCF, Josephs KA. Levodopa responsiveness in adult onset lower limb dystonia is associated with development of Parkinson’s disease. Tremor and Other Hyperkinetic Movement disorders. 3, 2013.

208. Richardson SP, Wegele AR, Skipper B, Deligtisch A, Jinnah HA, Rosen AR, Cho H, Chang FC- member of the dystonia coalition investigators. Dystonia treatment Patterns of medication use in an international cohort. Neurology, 88(6), 543-550, Jan 2017.

209. Norris, SA, Jinnah, HA, Espay, AJ, Klein, C, Brüggemann, N, Barbano, RL, Malaty, IAC, Rodriguez, RL, Vidailhet, M, Roze, E, Reich SG, Berman BD, LeDoux MS, PhD10, Richardson SP, Agarwal P, Mari Z, Ondo W, Shih LC, Fox S, Berardelli A, Testa CM, Chang FCF, Troung D, Nahab F, Xie T, Hallett M, Rosen AR, Wright LJ, Perlmutter JS. Clinical and demographic characteristics related to onset site and spread of cervical dystonia. Movement Disorders, 2016, 31(12), pp.1874-1882.

210. Fois AF, Chang FCF. Detecting dystonia in general practice. Medicines Today; 18 (11): 41-48. https://medicinetoday.com.au/2017/november/feature-article/detecting-dystonia

211. Duma SR, Ghattas S, Chang FCF. Internal Carotid Artery Occlusion Causing Acute Cranial Neuropathies. Journal of Stroke and Cerebrovascular Diseases. 2019 Apr 1;28(4):e5-6.

212. Norris SA, Jinnah HA, Klein C, Jankovic J, Berman BD, Roze E, Mahajan A, Espay AJ, Murthy AV, Fung VS, LeDoux MS, Chang FC – member of. Dystonia Coalition. Clinical and Demographic Characteristics of Upper Limb Dystonia. Movement Disorders. 2020 Aug 26.

212. Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter JS, Bäumer T, Usnich T, Berman BD, Mailly M, Chang FC – member of. Dystonia Coalition. Oromandibular Dystonia: A Clinical Examination of 2,020 Cases. Frontiers in Neurology. 2021;12.

213. Scorr LM, Factor SA, Parra SP, Kaye R, Paniello RC, Norris SA, Perlmutter J, Bäumer T, Usnich T, Berman B, Mailly M, Chang FC – member of. Dystonia Coalition. Delineation of the Clinical Features and Treatment Response of Oromandibular Dystonia: A Multicenter Summary of 2,057 Cases. medRxiv. 2020 Jan 1.

214. Scorr LM, Cho HJ, Kilic-Berkmen G, McKay JL, Hallett M, Klein C, Baumer T, Berman BD, Feuerstein JS, Perlmutter JS, Berardelli A, Chang FC – member of. Dystonia Coalition. Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022:2.

215. Younce JR, Cascella RH, Berman BD, Jinnah HA, Bellows S, Feuerstein J, Wagle Shukla A, Mahajan A, Chang FC, Duque KR, Reich S. Anatomical categorization of isolated non-focal dystonia: novel and existing patterns using a data-driven approach. Dystonia. 2023 Jun 8;2:11305.

216. Fellner A, Wali GM, Mahant N, Grosz BR, Ellis M, Narayanan RK, Ng K, Davis RL, Tchan MC, Kotschet K, Yeow D. Genome sequencing reanalysis increases the diagnostic yield in dystonia. Parkinsonism & Related Disorders. 2024 Jul 1;124:107010.

217. Bracken L, Tudehope F, Ryan WJ, Read S, Wilson D, Golubchik T, Gloss B, Bray S, Williams L, Waller S, Qiu J. Faecal microbiota transplant in advanced Parkinson's disease, microbial changes and effects on motor and gastrointestinal function: A randomised placebo controlled crossover study. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 2024 Sep 1 (Vol. 39, pp. 273-273).

218. Dawson J, Kay C, Black HF, Bortnick S, Javier K, Xia Q, Sandhu A, Buchanan C, Hogg V, Chang FC, Goto J. The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohort. Genetics in Medicine. 2024 Nov 1;26(11):101239.

219. Thomsen M, Ott F, Loens S, Kilic-Berkmen G, Tan AH, Lim SY, Lohmann E, Schröder KM, Ipsen L, Nothacker LA, Welzel L. Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing. medRxiv. 2024 Dec 5.

220. Nagaratnam SA, Wilson D, Chiang HL, Chang FCF, Qiu J, Silsby M, Fois AF, Martin A, Mahant N, Fung VSC, Morales-Briceno H. A Randomized, Double-Blind, Placebo Controlled, Crossover Trial of incobotulinumtoxinA Treatment for Upper Limb Tremor. Mov Disord Clin Pract. 2025 Apr 25.

221. Martino D, Ramezani M, Bellows S, Berman BD, Chang FC, Feuerstein J, Fung V, Berkmen GK, Malaty IA, MacIver C, Norris SA. Diagnostic Accuracy of Screening Tools for Depression and Anxiety in Cervical Dystonia. Parkinsonism & Related Disorders. 2025 May 26:107891.

Papers in Refereed Journals from Multi-centre Trials

1.     Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Huyck S, Wolski K. Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet Neurol 2011;10:221-9 (Site Principal Investigator)

2.     Giladi N, Boroojerdi B, Korczyn AD, Burn DJ, Clarke CE, Schapira AH; SP513investigators. Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord 2007;22:2398-404. (Site Principal Investigator)

3.     Barone P, Lamb J, Ellis A, Clarke Z. Sumanirole versus placebo or ropinirole for the adjunctive treatment of patients with advanced Parkinson's disease. Mov Disord 2007;22:483-9. (Site Principal Investigator)

4.     Ninan T. Mathew MD, Jean Schoenen MD, Paul Winner DO, Nancy Muirhead MS, Carolyn R. Sikes PhD (2003) Comparative Efficacy of Eletriptan 40 mg Versus Sumatriptan 100 mg. Headache: The Journal of Head and Face Pain 43 (3) , 214–222 (Site Principal Investigator)

5. McColgan P, Thobhani A, Boak L, Schobel SA, Nicotra A, Palermo G, Trundell D, Zhou J, Schlegel V, Sanwald Ducray P, Hawellek DJ. Tominersen in adults with manifest Huntington's disease. The New England journal of medicine. 2023 Dec 7;389(23):2203-5. (Site Sub-Investigator for GENERATION HD1)